Previous close | 3.4200 |
Open | 3.4400 |
Bid | 3.1500 x 800 |
Ask | 3.8900 x 900 |
Day's range | 3.3300 - 3.4900 |
52-week range | 3.1500 - 9.7900 |
Volume | |
Avg. volume | 505,508 |
Market cap | 274.849M |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | 10.58 |
EPS (TTM) | 0.3120 |
Earnings date | 08 May 2023 - 12 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.33 |
Every investor in Atea Pharmaceuticals, Inc. ( NASDAQ:AVIR ) should be aware of the most powerful shareholder groups...
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
Atea Pharmaceuticals, Inc. (AVIR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.